Working Knowledge
Business Research for Business Leaders
COVID-19 Business Impact Center
Filter Results: (116) Arrow Down

HealthRemove Health → HealthRemove Health →

Page 1 of 116 Results →

It's Time for a Bipartisan Health Plan for Employers and Employees

by Regina E. Herzlinger and Richard J. Boxer

Regina E. Herzlinger and Richard J. Boxer prescribe a seemingly impossible cure for battling health care options: a plan that embraces both Republican and Democratic ideas. Open for comment; Comment(s) posted.

Solving COVID'S Mental Health Crisis

by Howard Stevenson and Shirley Spence

COVID-19 affects more than physical health. Howard Stevenson and Shirley Spence describe how the pandemic is causing psychological trauma across a broad swath of society—and innovative methods to treat it. Open for comment; Comment(s) posted.

COVID-19 and the Workplace: Implications, Issues, and Insights for Future Research and Action

by Ashley Whillans and 28 coauthors

Assembling a large, diverse team of researchers to make sense of COVID-19’s impact on issues of work and organizational psychology, this project explores changes that are unfolding for practitioners and human resources professionals.

SmileDirect Looks Beyond Direct-to-Consumer Marketing

PODCAST: Teledentistry company SmileDirectClub is butting up against the limits of direct-to-consumer marketing. Len Schlesinger discusses his recent case study with Matt Higgins. Open for comment; Comment(s) posted.

Social Interactions in Pandemics: Fear, Altruism, and Reciprocity

by Laura Alfaro, Ester Faia, Nora Lamersdorf, and Farzad Saidi

An analysis of 89 cities worldwide shows that mobility responds to infection risk, altruism, and reciprocity. Correcting the SIR model to account for this behavior shows that a balanced approach involving stringency measures, in respect of human dignity, and responsible social preferences mitigates the pandemic health and economic costs.

A Mass Crisis Can Overwhelm Health Care. Liberia Found a Solution.

by Rachel Layne

Liberia trains community workers to help medical professionals on the front lines of disease control, says Brian Trelstad. Could the model work elsewhere? Open for comment; Comment(s) posted.

Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design

by Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver

Without a vaccine for COVID-19, the medical community has turned to a century-old therapy. This paper discusses a market design approach for expanding the collection and distribution of convalescent plasma.

In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?

Re: Tarun Khanna

How should the vaccine alliance Gavi respond to the worldwide need for a cure for the COVID-19 pandemic? Tarun Khanna discusses his case study. Open for comment; Comment(s) posted.

HBS COVID-19 Global Policy Tracker

by Alberto Cavallo and Tannya Cai

The Harvard Business School Covid-19 Global Policy Tracker monitors new developments and changes in government policies throughout this crisis to analyze trends and correlations in countries' responses and economic impact.

Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)

by Sorapop Kiatpongsan and Michael I. Norton

Across varying political ideologies and income levels, Americans both underestimate the current extent of inequality of mortality and healthcare, and prefer each to be more equally distributed.

Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.

by Pragya Kakani, Michael Chernew, and Amitabh Chandra

Retail pharmacy data illustrates it can be misleading to use list prices instead of net prices to understand pharmaceutical prices. Analysts and economists working in public policy should be extremely cautious in drawing policy conclusions based on list prices alone.

Demystifying the Math of the Coronavirus

by Elon Kohlberg and Abraham Neyman

This paper provides a conceptual model for the progression of COVID-19 that is somewhat imprecise but that’s very simple and easy to understand. By relying on this description, one can obtain a rough estimate of the impact of various social distancing measures on the rate of growth of new infections.

What South Korea Teaches the World About Fighting COVID

by Doug J. Chung

South Korea initially had the largest number of Coronavirus infections outside of China, but new cases have decreased sharply. What is the country doing right? asks Doug Chung. Open for comment; Comment(s) posted.

Why COVID-19 Raises the Stakes for Healthy Buildings

by Kristen Senz

Like it or not, humans have become an indoor species, so buildings have a major impact on our health. That's why the Healthy Building Movement is gaining momentum, say John Macomber and Joseph Allen. Open for comment; Comment(s) posted.

7 Leadership Principles for Managing in the Time of Coronavirus

by John A. Quelch

Leaders managing their organizations through crisis show seven distinctive capabilities, says John A. Quelch. Call them the seven Cs. Open for comment; Comment(s) posted.

These Coronavirus Heroes Show Us How Crisis Leadership Works

by Bill George

Now is the time for leaders to inspire their organizations to help the world through the COVID-19 crisis. Bill George has a list of authentic leaders who are up to the challenge. Open for comment; Comment(s) posted.

How Best Business Practices Can Improve Health Care

by Sean Silverthorne

Why do Harvard Business School scholars spend so much time and money analyzing health care delivery? Open for comment; Comment(s) posted.

Medicare for All or Public Option: Can Either Heal Health Care?

by Regina E. Herzlinger and James Wallace

A public insurance option could use its scale to hold prices down, but only if the approach avoids the financing gimmicks that are undermining Medicare, say Regina E. Herzlinger and James Wallace. Open for comment; Comment(s) posted.

Female Inventors and Inventions

by Rembrand Koning, Sampsa Samila, and John-Paul Ferguson

Does the gender of inventors make a difference for who benefits from their inventions? Analysis of all U.S. biomedical patents issued between 1976 and 2010 shows that research teams with women were more likely to produce patents addressing women’s health conditions, especially when female researchers led the teams. This link suggests that the dearth of women inventors might also result in fewer female-focused inventions.

Germany May Have the Answer for Reducing Drug Prices

by Danielle Kost

In Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Ariel Dora Stern asks whether "value-based pricing" should become the standard elsewhere. Open for comment; Comment(s) posted.